Effects and time-kill assessment of amoxicillin used in combination with chloramphenicol against bacteria of clinical importance

• Authors: Olufunmiso Olajuyigbe , Roger Coopoosamy , Anthony Afolayan
• Languages of publication: EN

Abstracts

EN

With the emergence of multidrug-resistant organisms in an era when drug development faces challenges causing pharmaceutical companies to curtail or abandon research on anti-infective agents, the use of combined existing antimicrobial agents may be an alternative. This study evaluated the effects of combining amoxicillin and chloramphenicol, to which many bacteria have become resistant, in vitro against Gram positive and Gram negative bacteria by agar diffusion, checkerboard and time-kill assays. The test isolates were susceptible to amoxicillin with minimum inhibitory concentrations (MICs) ranging between 0.448 and 500 µg/ml and between 1.953 and 31.25 µg/ml for chloramphenicol. Upon combining these agents, there was a drastic reduction in their MICs indicating an increased antibacterial activity that showed synergistic interaction against all the bacteria. At the highest concentrations, the inhibition zones ranges were 20.33-38.33±0.58 µg/ml for amoxicillin, 27.67-37.67±0.58 µg/ml for chloramphenicol and 31.67-39.33±0.58 µg/ml for the combined agents. The fractional inhibitory concentration indices (FICIs) showed synergy ranging from 0.129 to 0.312 while FICIs for additive interaction were between 0.688 and 1.0. There was no antagonistic interaction. At the 1/2MICs of the combined antibiotics, all the tested bacteria, except for Klebsiella pneumoniae ATCC 4352, Proteus vulgaris CSIR 0030 and Enterococcus cloacae ATCC 13047 were eliminated before 24 h. At the MICs, all the tested bacteria were eliminated except Enterococcus cloacae ATCC 13047 which was almost totally eliminated. Post-antibiotic assessment after 48 h showed that all the cultures were sterile except for that of Enterococcus cloacae ATCC 13047. The lack of antagonism between these antibacterial agents in checkerboard and time-kill assays suggested that combining amoxicillin with chloramphenicol can provide an improved therapy in comparison to the use of each antibiotic individually. The study indicates the potential beneficial value of combining amoxicillin and chloramphenicol in the treatment of microbial infections in clinical settings.

Keywords

EN

drug-drug interactions; fractional inhibitory concentrations; multidrug resistance; time-kill assessment

• Publisher: Polish Biochemical Society
• Journal: Acta Biochimica Polonica
• Year: 2017
• Volume: 64
• Issue: 4
• Pages: 609-613

Dates

published

2017

received

2016-12-31

revised

2017-02-13

accepted

2017-08-11

(unknown)

2017-11-30

Contributors

author

Olufunmiso Olajuyigbe

• Department of Nature Conservation, Mangosuthu University of Technology, Durban, KwaZulu-Natal, South Africa
• Medicinal Plants and Economic Development Research Centre, University of Fort Hare, Alice, 5700, South Africa

author

Roger Coopoosamy

• Department of Nature Conservation, Mangosuthu University of Technology, Durban, KwaZulu-Natal, South Africa

author

Anthony Afolayan

• Medicinal Plants and Economic Development Research Centre, University of Fort Hare, Alice, 5700, South Africa

References

• Aakra A, Vebø H, Indahl U, Snipen L, Gjerstad Ø, Lunde M, Nes IF (2010) The response of Enterococcus faecalis V583 to chloramphenicol treatment. Int J Microbiol Article ID 483048. doi: 10.1155/2010/483048.
• Abate A (2000) Anti-tuberculosis activity of β-lactam antibiotics: prospect for the treatment of MDR tuberculosis. Ethiop J Health Dev 14: 276-296
• Abate G, Miorner H (1998) Susceptibility of multidrug-resistant strains of Mycobacterium tuberculosis to amoxicillin in combination with clavulanic acid and ethambutol. J Antimicrob Chemother 42: 735-740.
• Bou G, Martïnez-Beltran J (2000) Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC β-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother 44: 428-432.
• Burns JL, Hedi LA, Lien DM (1989) Chloramphenicol resistance in Pseudomonas cepacia because of decreased permeability. Antimicrob Agents Chemother 33: 136-141. doi: 10.1128/AAC.33.2.136.
• Cameron EA, Powell KU, Baldwin L, Jones P, Bell GD, Williams SG (2004) Helicobacter pylori: antibiotic resistance and eradication rates in Suffolk, UK, 1991-2001. J Med Microbiol 53: 535–538. doi: 10.1099/jmm.0.05499-0.
• Clatworthy AE, Pierson E, Hung DT (2007) Targeting virulence: a new paradigm for antimicrobial therapy. Nat Chem Biol 3: 541-548. doi: 10.1038/nchembio.2007.2.
• Clinical and Laboratory Standards Institute (2009) M7-A8, Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard
• D'Costa VM, McGrann KM, Hughes DW, Wright GD (2006) Sampling the antibiotic resistome. Science 311: 374-377. doi: 10.1126/science.1120800.
• Daniels C, Ramos JL (2009) Adaptive drug resistance mediated by root-nodulation-cell division efflux pumps. Clin Microbiol Infect 15 (Suppl 1): 32-36. doi: 10.1111/j.1469-0691.2008.02693.x.
• Das U, Bhattacharya SS (2000) Multidrug resistant Salmonella typhi in Rourkela, Orissa. Indian J Pathol Microbiol 43: 135-138.
• Daschner FD (1976) Combination of bacteriostatic and bactericidal drugs: lack of significant in vitro antagonism between penicillin, cephalothin and rolitetracycline. Antimicrob Agents Chemother 10: 802-808.
• Edgar R, Friedman N, Molshanski-Mor S, Qimron U (2012) Reversing bacterial resistance to antibiotics by phage-mediated delivery of dominant sensitive genes. Appl Environ Microbiol 78: 744-751. doi: 10.1128/AEM.05741-11.
• EUCAST (2013) The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 3.1, 2013. http://www.eucast.org/clinical_breakpoints/ (Accessed: 6th November, 2016)
• Fox PM, Lampen RJ, Stumpf KS, Archer GL, Climo MW (2006) Successful therapy of experimental endocarditis caused by vancomycin-resistant Staphylococcus aureus with a combination of vancomycin and beta-lactam antibiotics. Antimicrob Agents Chemother 50: 2951-2956. doi: 10.1128/AAC.00232-06.
• Getahun A (2000) Anti-tuberculosis activity of β-lactam antibiotics: prospect for the treatment of MDR tuberculosis. Ethiop J Health Dev 14: 276-296. doi: 10.4314/ejhd.v14i3.276
• Güzel CB, Gerçeker AA (2008) In vitro activities of various antibiotics, alone and in combination with colistin methanesulfonate, against Pseudomonas aeruginosa strains isolated from cystic fibrosis patients. Chemotherapy 54: 147-151. doi: 10.1159/000119741.
• Hall MJ, Middleton RF, Westmacott D (1983) The fractional inhibitory concentration (FIC) index as a measure of synergy. J Antimicrob Chemother 11: 427-433. doi: 10.1093/jac/11.5.427.
• Kabra SK, Madhulika, Talati A, Soni N, Patel S, Modi RR (2000) Multidrug-resistant typhoid fever. Trop Doct 30: 195-197.
• Kumar A, Schweizer HP (2005) Bacterial resistance to antibiotics: active efflux and reduced uptake. Adv Drug Deliv Rev 57: 1486-513.
• Lynch JP 3rd, Zhanel GG (2005) Escalation of antimicrobial resistance among Streptococcus pneumoniae: implications for therapy. Semin Respir Crit Care Med 26: 575-616. doi: 10.1055/s-2005-925524.
• Maviglia R, Nestorini R, Pennisi M (2009) Role of old antibiotics in multidrug resistant bacterial infections. Curr Drug Targets 10: 895-905. doi: 10.2174/138945009789108846.
• Montero CI, Johnson MR, Chou CJ, Conners SB, Geouge SG, Tachdjian S, Nichols JD, Kelly RM (2007) Responses of wild-type and resistant strains of the hyperthermophilic bacterium thermotoga maritime to chloramphenicol challenge. Appl Environ Microbiol 73: 5058-5065. doi: 10.1128/AEM.00453-07.
• Nitzan O, Suponitzky U, Kennes Y, Chazan B, Raul R, Colodner R (2010) Is chloramphenicol making a comeback? Isr Med Assoc J 12: 371-374.
• Normark BH, Normark S (2002) Evolution and spread of antibiotic resistance. J Intern Med 252: 91-106. doi: 10.1046/j.1365-2796.2002.01026.x.
• Pankey G, Ashcraft D, Patel N (2005) In vitro synergy of daptomycin plus rifampin against Enterococcus faecium resistant to both linezolid and vancomycin. Antimicrob Agents Chemother 49: 5166-5168. doi: 10.1128/AAC.49.12.5166-5168.2005.
• Petersen PJ, Labthavikul P, Jones CH, Bradford PA (2006) In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis. J Antimicrob Chemother 57: 573-576. doi: 10.1093/jac/dki477.
• Schwarz S, Kehrenberg C, Doublet B, Cloeckaert A (2004) Molecular basis of bacterial resistance to chloramphenicol and florfenicol. FEMS Microbiol Rev 28: 519-542. doi: 10.1016/j.femsre.2004.04.001.
• Shahhet L, Alraghban D, Chehna D (2011) Improvement of the physicochemical properties of amoxicillin trihydrate powder by recrystallization at different pH values. Int J Pharm Pharmaceut Sci 3 (Suppl 3): 92-100
• Smith E, Williamson M, Wareham N, Kaatz G, Gibbons S (2007) Antibacterials and modulators of bacterial resistance from the immature cones of Chamaecyparis lawsoniana. Phytochemistry 68: 210-217. doi: 10.1016/j.phytochem.2006.10.001.
• Spahn CM, Prescott CD (1996) Throwing a spanner in the works: antibiotics and the translation apparatus. J Mol Med 74: 423-439. doi: 10.1007/BF00217518.
• Yellanki SK, Singh J, Ali SJ (2010) Design and characterization of amoxicillin trihydrate mucoadhesive microspheres for prolonged gastric retention. Int J Pharm Sci Drug Res 2: 112-114
• Zhang R, Eggleston K, Rotimi V, Zeckhauser RJ (2006) Antibiotic resistance as a global threat: Evidence from China, Kuwait and the United States. Globalization and Health 2: 6. doi: 10.1186/1744-8603-2-6.

Identifiers

DOI

10.18388/abp.2016_1495